Show Notes for September 2018 – Episode 24 * Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis  – Gastro * Safety and efficacy of elobixibat for chronic  constipation–  The Lancet: Gastro * Oral Anticoagulation in Patients With Liver Disease – JACC * Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases – Gastro * Risk of Oral and Upper GI cancer in FIT-positive Colorectal cancer screening program. – CGH * Extraintestinal Manifestations in Vedolizumab and  Anti-TNFTreated Patients With Inflammatory Bowel Disease – IBD Journal * Personalized Gut Mucosal Colonization Resistance to Empiric Probiotics Is Associated with Unique Host and Microbiome Features – Cell * Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT – Cell * Beyond O&P Times Three – Am J Gastro * Helicobacter Pylori Infection Does Not Protect Against Eosinophilic Esophagitis – Am J Gastro Tweet